Header image

Session D: Oral Abstracts

Tracks
.
Wednesday, September 6, 2017
1:00 PM - 2:20 PM
Manhattan Ballroom

Speaker

Attendee97

Hepatitis C Cascade of Care among People who Inject Drugs in Vancouver, Canada

1:00 PM - 1:15 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Attendee280

Ten-Fold Increase in HCV Treatment Uptake among People who Inject Drugs Following Broad Access to DAA Therapies in Australia

1:15 PM - 1:30 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Attendee24

Reaching Hepatitis C Virus Elimination Targets Requires Health System Interventions to Enhance the Care Cascade

1:30 PM - 1:45 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Attendee402

Cost-Effectiveness of Scaling Up HCV Prevention, Testing and Treatment Interventions among People who Inject Drugs in the US

1:45 PM - 2:00 PM

Abstract

Biography

Attendee394

Interventions to Enhance Testing, Linkage-to-Care and Treatment Uptake for Hepatitis C Infection among People who Inject Drugs: A Systematic Review

2:00 PM - 2:05 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Attendee218

Poor Awareness of Hepatitis C Virus Antiviral Effectiveness among People who Actively Inject Drugs in the Direct-Acting Antiviral Era

2:05 PM - 2:10 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Attendee315

A One-Step Diagnosis Algorithm Reveals High Burden of Hepatitis C among People who Inject Drugs in Spain and the Urgency for Improved Linkage-to-Care

2:10 PM - 2:15 PM

Abstract

Speaker Presentation

Biography

Attendee184

Project ITTREAT (Integrated Community Based Test-stage and TREAT) HCV Service for People Who Inject Drugs (PWID)

2:15 PM - 2:20 PM

Abstract

Speaker Presentation

Video Presentation

Biography

Footer image
loading